Ritonga MA

No ORCID on file · 9 papers in corpus · active 2024-2026

Study types

  • article 4
  • other 3
  • preprint 1
  • review 1

Condition tags

  • endometriosis 7
  • dysmenorrhea 3
  • chronic_pelvic_pain 2
  • dyspareunia 1
  • infertility 1
  • endometrioma 1
  • adenomyosis 1
article 2026

Yohanes Iddo Adventa, Anita Rachmawati, Dian Tjahyadi, Mulyanusa Amarullah Ritonga Division of Fertility and Reproductive Endocrinology, Department of Obstetrics and Gynecology, Faculty of Medicine, Dr. Hasan Sadikin General Hospital, Padja…

article 2026

Haidarotul Milla,1 Mulyanusa Amarullah Ritonga,2 Hartanto Bayuaji,2 Agus Heriyanto,1 Fikry Haerusulistio Direza3 1Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University,…

article 2026

Agus Heriyanto,1 Dian Tjahyadi,1 Hartanto Bayuaji,1 Ruswana Anwar,1 Hanom Husni Syam,1 Mulyanusa Amarullah Ritonga,1 Binarwan Halim,2 Luky Adlino3 1Reproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology…

other 2026
SAGE open medicine ·doi:10.1177/20503121251409312

OBJECTIVE: Endometriosis is a chronic gynecological disease associated with inflammation and severe pelvic pain in 6%-10% of women of reproductive age. Although the pathophysiology and management of endometriosis are currently understood, f…

other 2026
SAGE open medicine ·doi:10.1177/20503121261420031

INTRODUCTION: Endometriosis is a major gynecologic health issue affecting ~10% of women and girls of reproductive age worldwide. Despite its high prevalence, no curative treatment exists. Early diagnosis and treatment are critical to preven…

other 2025
Scientific reports ·doi:10.1038/s41598-024-85017-4

Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial-like tissues (glands and stroma) located outside the uterine cavity. The pathophysiology of this condition remains incompletely understood. Local b…

review 2025
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v23i9.20156

BACKGROUND: Elagolix, Linzagolix, and Relugolix, as oral gonadotropin-releasing hormone antagonists, have emerged as promising treatments for endometriosis-associated pain. OBJECTIVE: To evaluate pain intensity reduction as the primary out…

article 2025
SAGE open medicine ·doi:10.1177/20503121251332405

BACKGROUND: Endometriosis involves the presence of endometrial-like tissue outside the uterus, driven by inflammatory pathways including elevated interleukin-32 and vascular endothelial growth factor. One potential anti-inflammatory agent i…

preprint 2024
·doi:10.21203/rs.3.rs-4759160/v1

Abstract Endometriosis involves the presence of endometrial-like tissue outside the uterus, driven by inflammatory pathways including elevated Interleukin-32 (IL-32) and Vascular Endothelial Growth Factor (VEGF). One potential anti-inflamm…